BAFF
bioAffinity increases authorized common and preferred stock shares
The company amended its certificate of incorporation to raise the authorized total number of shares from 150,000,000 to 220,000,000. This regulatory change provides greater flexibility for potential future fund-raising activities in the capital markets.